This article is more than 5 years old. Information may no longer be current.
Cardiology Today Editorial Board voted on top stories of 2011
Click Here to Manage Email Alerts
The Cardiology Today Editorial Board scanned the headlines appearing in 2011 and chose the 10 most important stories appearing in our pages last year, with new advances in transcatheter aortic valve replacement topping the list. Their votes were tallied and the rest of the Top 10 list is on page 7. Our yearly Top 10 list provides the Editorial Board and readers with the opportunity to look back at the major developments in CV medicine during the past year. The editors of Cardiology Today value your opinion. Let us know what you think about our Top 10 list.
The following are the Top 10 stories of 2011, in order of their importance, covered by Cardiology Today. They were selected by members of the Cardiology Today Editorial Board from a list of 25 stories provided by the editorial staff.
2. New advances with factor Xa inhibitors on stroke prevention: Apixaban bested warfarin for stroke prevention in AF; rivaroxaban approved to reduce risks for stroke, systemic embolism in AF
3. Dronedarone doubled mortality risk in halted PALLAS study
4. STICH: CABG plus medical therapy yields marginal benefit in patients with HF, CAD
5. AIM-HIGH: Study halted prematurely; new data show no additive benefit of niacin to statin therapy
6. FDA approved ticagrelor for use in ACS
7. ATLAS ACS-TIMI 51: Adding low dose rivaroxaban to antiplatelet therapy reduced death rates in ACS
8. UN mobilizes governments in fight against noncommunicable diseases
9. Elective angioplasty patients fare well in hospitals without on-site cardiac surgery
10. SYNTAX: Death rates diverge at 4 years